HOPE Therapeutics and a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP) announced signing of a Binding Term Sheet with Smith & Sauer, LLC, for $25 million equity purchases to fund planned HOPE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback